DLD Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

DLD Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-239,762	Closed	-$31.5M	–	172
2020 Q4	$31.5M	Buy	+239,762	New	+$21.2M	0.89%	15

DLD Asset Management's EIDX Position: Q1 2021 in Review

DLD Asset Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 239,762 shares — an estimated $31.5M sold.

DLD Asset Management first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $31.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

DLD Asset Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
DLD Asset Management sold 239,762 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $31.5M.
DLD Asset Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
DLD Asset Management's Eidos Therapeutics, Inc. Common Stock position peaked at $31.5M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on DLD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.